Meghmani Organics Limited Q1 profit rises 280% as revenue falls

Meghmani Organics Limited reported consolidated net profit of ₹48.2 crore for Q1 FY27, up 280% year-on-year, even as consolidated revenue fell 11.5% to ₹543 crore in the quarter ended June 2026. The result shows a substantial improvement in profitability despite softer demand and lower sales.

What did Meghmani Organics report in Q1 FY27?

Meghmani Organics reported consolidated revenue of ₹543 crore and net profit of ₹48.2 crore for the June 2026 quarter. Revenue was down 11.5% year-on-year, while profit rose 280% from the corresponding quarter of the previous financial year.

The company said its Q1 FY27 revenue decline reflected soft demand. However, profitability improved sharply, supported by a more favourable product mix and operational efficiencies. Consolidated EBITDA rose 46% year-on-year to ₹97.9 crore, while the operating margin for the quarter was reported at 18.0%.

The reported figures show that the company generated higher operating profit on a lower revenue base. Quarterly sales data also show revenue rising from ₹474 crore in Q4 FY26 to ₹543 crore in Q1 FY27, while operating profit increased from ₹20 crore to ₹98 crore over the same period.

Why did profit improve despite lower revenue?

Meghmani Organics attributed the improvement in consolidated profit to an optimised product mix and operational efficiencies. These factors helped lift EBITDA to ₹97.9 crore even though demand conditions affected the top line.

The difference between consolidated and standalone figures is material for investors reviewing the release. On a standalone basis, revenue was ₹522.94 crore, down 11.7% year-on-year, while net profit rose 42.2% to ₹57.60 crore. The consolidated results, which include the financial performance of subsidiaries, showed revenue of ₹543 crore and profit of ₹48.2 crore.

The company has also identified its Crop Protection business as an important operating area. In the Q2-related information available before the formal result announcement, Crop Protection revenue was stated at ₹443 crore and segment EBITDA at ₹75 crore. Those figures were accompanied by references to challenges in Pigment and Titanium Dioxide operations, including continuing losses in the Titanium Dioxide segment.

How has Meghmani Organics performed in recent quarters?

Meghmani Organics' latest quarterly performance follows a period of volatile revenue and improving operating profit. Sales were ₹614 crore in the June 2025 quarter, ₹577 crore in September 2025, ₹509 crore in December 2025, ₹474 crore in March 2026 and ₹543 crore in June 2026.

Operating profit moved from ₹67 crore in June 2025 to ₹52 crore in September 2025, ₹38 crore in December 2025 and ₹20 crore in March 2026. It then rose to ₹98 crore in June 2026. This sequence provides context for the Q1 FY27 margin improvement, though revenue remained below the June 2025 level.

The available quarterly result history also shows that market reactions following earnings releases have varied. The share price moved from ₹56.32 to ₹55.30 after the Q1 FY27 release, a decline of 1.8%. Following the Q4 FY26 result, it fell 5.3%, from ₹52.07 to ₹49.33.

What is scheduled for Meghmani Organics' Q2 FY27 results?

Meghmani Organics' board was scheduled to meet on 4 November 2026 to consider the unaudited Q2 FY27 and half-year FY2026-27 financial results. The quarter covers the July-September 2026 period.

The company has also scheduled a post-earnings call for 5 November 2026 at 11:00 a.m. The call is intended to discuss the Q2 FY27 financial results, with participation indicated from the Chairman, Chief Financial Officer and investor-relations team.

No Q2 FY27 financial figures are included in the supplied announcement. Investors therefore have the Q1 FY27 performance as the latest reported financial benchmark, while the board meeting and subsequent earnings call are the disclosed next events for updated information.

How do the results matter for investors and operations?

The Q1 FY27 numbers matter because Meghmani Organics improved profit and EBITDA while revenue declined. The reported 18.0% operating margin and ₹97.9 crore EBITDA indicate that product mix and operating efficiencies had a meaningful effect on quarterly earnings.

At the same time, the revenue decline points to continuing demand-related pressure. The company has indicated a focus on high-value, low-volume products and expansion of its Crop Nutrition business. It has also cited US tariff effects and losses in Titanium Dioxide as challenges affecting parts of its operations.

For shareholders, the next disclosures will be relevant for assessing whether the June-quarter margin improvement continued into Q2. The scheduled board meeting and investor call provide the next company-led update on revenue, segment performance, profitability and management commentary.

Conclusion

Meghmani Organics Limited entered Q2 FY27 after reporting a sharp improvement in Q1 profitability. Consolidated net profit rose 280% year-on-year to ₹48.2 crore and EBITDA increased 46% to ₹97.9 crore, while revenue declined 11.5% to ₹543 crore amid soft demand. The result reflects stronger operating performance but also underscores pressure on sales growth.

Investors should watch the Q2 FY27 financial results considered by the board on 4 November 2026 and management's comments during the 5 November earnings call. Key disclosed areas to monitor include demand conditions, Crop Protection performance, the Crop Nutrition expansion, US tariff effects and losses in the Titanium Dioxide business.